Dynamic Prediction of 5-year Overall Survival in Stage I,II,III Colon Cancer Patients

被引：0
作者：
Battagello, J. [1 ]
Capelli, G. [2 ]
Restivo, A. [3 ]
Bao, Q. [2 ]
Deidda, S. [3 ]
Zorcolo, L. [3 ]
Pucciarelli, S. [2 ]
Zorzi, M. [1 ]
Spolverato, G. [2 ]
机构：
[1] Azienda Zero, Veneto Tumor Registry, Padua, Italy
[2] Univ Padua, Dept Surg Oncol & Gastroenterol Sci, Surg Clin 1, Padua, Italy
[3] Univ Cagliari, Cagliari, Italy
来源：
ANNALS OF SURGICAL ONCOLOGY | 2021年 / 28卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P88
引用
收藏
页码：S78 / S79
页数：2
相关论文
共 50 条
  • [31] Genetic Variant Associated With Survival of Patients With Stage II-III Colon Cancer
    Penney, Kathryn L.
    Banbury, Barbara L.
    Bien, Stephanie
    Harrison, Tabitha A.
    Hua, Xinwei
    Phipps, Amanda I.
    Sun, Wei
    Song, Mingyang
    Joshi, Amit D.
    Alberts, Steven R.
    Allegra, Carmen J.
    Atkins, James
    Colangelo, Linda H.
    George, Thomas J.
    Goldberg, Richard M.
    Lucas, Peter C.
    Nair, Suresh G.
    Shi, Qian
    Sinicrope, Frank A.
    Wolmark, Norman
    Yothers, Greg
    Peters, Ulrike
    Newcomb, Polly A.
    Chan, Andrew T.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (12) : 2717 - +
  • [32] Genomic profiling of stage II and III colon cancers reveals APC mutations to be associated with survival in stage III colon cancer patients
    van den Broek, Evert
    Krijgsman, Oscar
    Sie, Daoud
    Tijssen, Marianne
    Mongera, Sandra
    van de Wiel, Mark A.
    Belt, Eric J. Th.
    den Uil, Sjoerd H.
    Bril, Herman
    Stockmann, Hein B. A. C.
    Ylstra, Bauke
    Carvalho, Beatriz
    Meijer, Gerrit A.
    Fijneman, Remond J. A.
    ONCOTARGET, 2016, 7 (45) : 73876 - 73887
  • [33] Does the Presence of Matted Nodes in Colon Adenocarcinoma Influence 5-Year Overall Survival?
    Rodriguez-Lopez, Karla I.
    Salazar-Castillo, Mariana
    Lino-Silva, Leonardo S.
    Galan-Ramirez, Angeles
    Rivera-Moncada, Luisa F.
    Lopez-Jimenez, Emiliano A.
    Zepeda-Najar, Cesar
    MEDICINA-LITHUANIA, 2024, 60 (08):
  • [34] Immunomonitoring in patients with stage II and III colon cancer
    Vocka, Michal
    Spacek, Jan
    Netikova, Irena
    Zavadova, Eva
    Nemejcova, Kristyna
    Konopasek, Bohuslav
    Dundr, Pavel
    Geppert, Carol-Immanuel
    Fucikova, Terezie
    Hartmann, Arndt
    Petruzelka, Lubos B.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [35] Is there hope in improving 5-year overall survival?-review of 5-year overall survival data from KEYNOTE-001
    Akingbemi, Wisdom
    Garon, Edward
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (11)
  • [36] Implementation of enhanced recovery after surgery and its increasing compliance improved 5-year overall survival in resectable stage III colorectal cancer
    Lohsiriwat, Varut
    Lertbannaphong, Sarinda
    Polakla, Bundhawich
    Riansuwan, Woramin
    UPDATES IN SURGERY, 2021, 73 (06) : 2169 - 2179
  • [37] Implementation of enhanced recovery after surgery and its increasing compliance improved 5-year overall survival in resectable stage III colorectal cancer
    Varut Lohsiriwat
    Sarinda Lertbannaphong
    Bundhawich Polakla
    Woramin Riansuwan
    Updates in Surgery, 2021, 73 : 2169 - 2179
  • [38] Development of Prediction Model for 5-year Survival of Colorectal Cancer
    Nopour, Raoof
    CANCER INFORMATICS, 2024, 23
  • [39] Lymph Node Evaluation and Survival in Stage II and III Colon Cancer
    Badgwell, Brian
    Chang, George J.
    SEMINARS IN COLON AND RECTAL SURGERY, 2008, 19 (01) : 26 - 29
  • [40] CARE FRAGMENTATION AND SURVIVAL FOR PATIENTS WITH STAGE III COLON CANCER
    Hussain, Tanvir
    Chang, Hsien-Yen
    Veenstra, Christine M.
    Pollack, Craig E.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2014, 29 : S45 - S46
12345